Litt’s Drug profile for Hyoscyamine


BreastfeedingGeriatricPediatric
  • Trade Names: Anaspaz; Cytospaz; Donnamar; Duboisine; ED-SPAZ; Egacene Durettes; Egazil; Gastrosed; Hyco; Hycosol Sl; Hyospaz; IB-Stat (InKline); Levbid (Schwarz); Levsin (Schwarz); Levsin/SL (Schwarz); Levsinex (Schwarz); Medispaz; Nulev (Schwarz); Pasmex; Peptard; Setamine; Urised
  • Indications: Treatment of gastrointestinal tract disorders caused by spasm, adjunctive therapy for peptic ulcers, cystitis, Parkinsonism, biliary and renal colic
  • Class: Anticholinergic, Muscarinic antagonist
  • Half-life: N/A
  • Clinically important, potentially hazardous interactions with:
    Anticholinergics, Arbutamine

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top